Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Pharmacology, Biochemistry, and Behavior
|
October 1, 1985
Pharmacological and clinical effects of buspirone
D P Taylor, M S Eison, L A Riblet, et al.
The Journal of Clinical Psychiatry
|
December 1, 1982
Pharmacology and neurochemistry of buspirone
L A Riblet, D P Taylor, M S Eison, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
May 1, 1984
Determination of functionally-relevant serum levels of MJ 13859-1 in the dog: relationship to blockade of amphetamine stereotypy
M S Eison, D P Taylor, L A Riblet, et al.
Psychopharmacology Bulletin
|
January 1, 1990
Nefazodone: preclinical pharmacology of a new antidepressant
A S Eison, M S Eison, J R Torrente, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1983
Buspirone: an anxioselective alternative for the management of anxiety disorders
L A Riblet, A S Eison, M S Eison, et al.
Psychopathology
|
January 1, 1984
Neuropharmacology of buspirone
L A Riblet, A S Eison, M S Eison, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1982
Dopamine and antianxiety activity
D P Taylor, L A Riblet, H C Stanton, et al.
Journal of Medicinal Chemistry
|
August 1, 1986
Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives
J S New, J P Yevich, M S Eison, et al.
Journal of Medicinal Chemistry
|
December 7, 1992
Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents
J P Yevich, J S New, W G Lobeck, et al.
Journal of Medicinal Chemistry
|
March 1, 1988
Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives
J S New, J P Yevich, D L Temple, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Pharmacology, Biochemistry, and Behavior
|
October 1, 1985
Pharmacological and clinical effects of buspirone
D P Taylor, M S Eison, L A Riblet, et al.
The Journal of Clinical Psychiatry
|
December 1, 1982
Pharmacology and neurochemistry of buspirone
L A Riblet, D P Taylor, M S Eison, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
May 1, 1984
Determination of functionally-relevant serum levels of MJ 13859-1 in the dog: relationship to blockade of amphetamine stereotypy
M S Eison, D P Taylor, L A Riblet, et al.
Psychopharmacology Bulletin
|
January 1, 1990
Nefazodone: preclinical pharmacology of a new antidepressant
A S Eison, M S Eison, J R Torrente, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1983
Buspirone: an anxioselective alternative for the management of anxiety disorders
L A Riblet, A S Eison, M S Eison, et al.
Psychopathology
|
January 1, 1984
Neuropharmacology of buspirone
L A Riblet, A S Eison, M S Eison, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1982
Dopamine and antianxiety activity
D P Taylor, L A Riblet, H C Stanton, et al.
Journal of Medicinal Chemistry
|
August 1, 1986
Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives
J S New, J P Yevich, M S Eison, et al.
Journal of Medicinal Chemistry
|
December 7, 1992
Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents
J P Yevich, J S New, W G Lobeck, et al.
Journal of Medicinal Chemistry
|
March 1, 1988
Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives
J S New, J P Yevich, D L Temple, et al.
Page
of 4